Mercer Global Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-79,289
| Closed | -$224K | – | 1227 |
|
|
2020
Q1 | $224K | Sell |
79,289
-3,747
| -5% | -$10.6K | ﹤0.01% | 912 |
|
|
2019
Q4 | $269K | Buy |
83,036
+16,378
| +25% | +$53.1K | 0.01% | 960 |
|
|
2019
Q3 | $143K | Buy |
66,658
+4,692
| +8% | +$10.1K | ﹤0.01% | 1056 |
|
|
2019
Q2 | $195K | Buy |
61,966
+127
| +0.2% | +$400 | 0.01% | 1060 |
|
|
2019
Q1 | $230K | Buy |
+61,839
| New | +$230K | 0.01% | 936 |
|